NPCE News and Press, Neuropace Inc. From 11/24/25

--Physician Fee Schedule (PFS) final rule substantially increases reimbursement for RNS neurostimulator implantation and replacement procedures-- --CY 2026 Outpatient Prospective Payment System (OPPS) Final Rule moves RNS replacement procedures to highest-paying neurostimulator APC-- ...

2025-11-04 23:07:14 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q2 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript NeuroPace GAAP EPS of -$0.11 beats by $0.09...

2025-11-04 23:06:27 ET NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Scott Scaper Joel Becker - CEO, President & Director Patrick Williams - Chief Financial Officer ... Read the full article on Seeking ...

2025-11-04 16:26:35 ET More on NeuroPace NeuroPace, Inc. 2025 Q2 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript NeuroPace raises 2025 revenue guidance to $94M-$98M as RNS System drives record growth Seeking Alph...

-- Reported record quarterly revenue of $27.4 million in Q3 2025 representing 30% growth -- -- Increased full-year 2025 revenue guidance to between $97 million and $98 million and gross margin guidance to between 76% and 77% -- -- Remains on track to submit NAUTILUS PMA Supple...

Advanced Energy Industries Inc. (AEIS) is expected to report $1.16 for Q3 2025 Neuropace Inc. (NPCE) is expected to report $-0.2 for Q3 2025 Oportun Financial Corporation (OPRT) is expected to report $0.2 for Q3 2025 trivago N.V. (TRVG) is expected to report $0.07 for Q3 2025 Alle...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2025 after market close on Tuesday, November 4, 2025. The company’s management will webcast a...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in two healthcare conferences in September. NeuroPace management will host one-on-one meetings with investors ...

2025-08-12 21:51:27 ET More on NeuroPace NeuroPace, Inc. 2025 Q2 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript NeuroPace: Volatile, Uncertain, But Promising NeuroPace secures $75M credit facility with MidCap Fi...

2025-08-12 21:50:30 ET NeuroPace, Inc. (NPCE) Q2 2025 Earnings Conference Call August 12, 2025 04:30 PM ET Company Participants Joel D. Becker - CEO, President & Director Patrick F. Williams - Chief Financial Officer Conference Call Participants Frank...